Exploring the Osteoinductive Potential of Bacterial Pyomelanin Derived from Pseudomonas aeruginosa in a Human Osteoblast Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413406 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mateusz M Urbaniak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha St, 90-237 Łódź, …. Hauptthemen laut MEDLINE: Osteoblasts, Pseudomonas aeruginosa, Melanins, Osteogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Polish Science, IDUB Interdisciplinary Research Grants, European Regional Development Fund.
Abstract (Originalsprache)
Alkaptonuria (AKU) is a genetically determined disease associated with disorders of tyrosine metabolism. In AKU, the deposition of homogentisic acid polymers contributes to the pathological ossification of cartilage tissue. The controlled use of biomimetics similar to deposits observed in cartilage during AKU potentially may serve the development of new bone regeneration therapy based on the activation of osteoblasts. The proposed biomimetic is pyomelanin (PyoM), a polymeric biomacromolecule synthesized by Pseudomonas aeruginosa. This work presents comprehensive data on the osteoinductive, pro-regenerative, and antibacterial properties, as well as the cytocompatibility, of water-soluble (PyoMsol) or water-insoluble (PyoMinsol) PyoM. Both variants of PyoM support osteoinductive processes as well as the maturation of osteoblasts in cell cultures in vitro due to the upregulation of bone-formation markers, osteocalcin (OC), and alkaline phosphatase (ALP). Furthermore, the cytokines involved in these processes were elevated in cell cultures of osteoblasts exposed to PyoM: tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10. The PyoM variants are cytocompatible in a wide concentration range and limit the doxorubicin-induced apoptosis of osteoblasts. This cytoprotective PyoM activity is correlated with an increased migration of osteoblasts. Moreover, PyoMsol and PyoMinsol exhibit antibacterial activity against staphylococci isolated from infected bones. The osteoinductive, pro-regenerative, and antiapoptotic effects achieved through PyoM stimulation prompt the development of new biocomposites modified with this bacterial biopolymer for medical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha St, 90-237 Łódź, Poland.
- Department of Inorganic and Analytical Chemistry, Faculty of Chemistry, University of Lodz, 12 Tamka St, 91-403 Łódź, Poland.
ORCID-Profile: Mateusz M Urbaniak, Karolina Rudnicka, Przemysław Płociński
Förderung
- Foundation for Polish Science
- IDUB Interdisciplinary Research Grants
- European Regional Development Fund
- pyomelanin photovoltaic cells
- University of Lodz
Zitieren
APA
Urbaniak, M. M., Rudnicka, K., Płociński, P., & Chmiela, M. (2024). Exploring the Osteoinductive Potential of Bacterial Pyomelanin Derived from Pseudomonas aeruginosa in a Human Osteoblast Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413406
Vancouver
Urbaniak MM, Rudnicka K, Płociński P, Chmiela M. Exploring the Osteoinductive Potential of Bacterial Pyomelanin Derived from Pseudomonas aeruginosa in a Human Osteoblast Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413406
BibTeX
@article{Urbaniak2024,
author = {Urbaniak, Mateusz M and Rudnicka, Karolina and Płociński, Przemysław and Chmiela, Magdalena},
title = {Exploring the Osteoinductive Potential of Bacterial Pyomelanin Derived from Pseudomonas aeruginosa in a Human Osteoblast Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413406}
}
EUVIMED